BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 3347279)

  • 1. [Recombinant human erythropoietin].
    Frenken LA; Koene RA
    Ned Tijdschr Geneeskd; 1988 Mar; 132(10):432-4. PubMed ID: 3347279
    [No Abstract]   [Full Text] [Related]  

  • 2. Reversing the anemia of renal failure.
    Hatch FE
    Hosp Pract (Off Ed); 1990 Feb; 25(2A):25-34. PubMed ID: 2105980
    [No Abstract]   [Full Text] [Related]  

  • 3. [Human recombinant erythropoietin: from clinical aspects to the physiopathology of anemia of renal insufficiency].
    Wauters JP
    Rev Med Suisse Romande; 1990 Nov; 110(11):951-4. PubMed ID: 2267466
    [No Abstract]   [Full Text] [Related]  

  • 4. [Recombinant human erythropoietin].
    Montloin A
    Rev Infirm; 1990 Dec; 40(19):33-4. PubMed ID: 2091207
    [No Abstract]   [Full Text] [Related]  

  • 5. Analysis of initial resistance of erythropoiesis to treatment with recombinant human erythropoietin. Results of a multicenter trial in patients with end-stage renal disease.
    Kühn K; Nonnast-Daniel B; Grützmacher P; Grüner J; Pfåffl W; Baldamus CA; Scigalla P
    Contrib Nephrol; 1988; 66():94-103. PubMed ID: 3292152
    [No Abstract]   [Full Text] [Related]  

  • 6. Dose-related effects of recombinant human erythropoietin on erythropoiesis. Results of a multicenter trial in patients with end-stage renal disease.
    Bommer J; Kugel M; Schoeppe W; Brunkhorst R; Samtleben W; Bramsiepe P; Scigalla P
    Contrib Nephrol; 1988; 66():85-93. PubMed ID: 3292151
    [No Abstract]   [Full Text] [Related]  

  • 7. [Recombinant human erythropoietin in the treatment of the anemia of multiple myeloma with kidney failure].
    Arenas Gracia M; Abad Gosálvez A; Colomina Avilés J; Pascual Pérez R; Ferriz Moreno P
    An Med Interna; 1995 Apr; 12(4):187-8. PubMed ID: 7620064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigating erythropoietin resistance.
    Koury MJ
    N Engl J Med; 1993 Jan; 328(3):205-6. PubMed ID: 8417388
    [No Abstract]   [Full Text] [Related]  

  • 9. Anemia in hemodialysis patients.
    Higgins MR; Grace M; Ulan RA; Silverberg DS; Bettcher KB; Dossetor JB
    Arch Intern Med; 1977 Feb; 137(2):172-6. PubMed ID: 836115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant erythropoietin as treatment for the late hyporegenerative anemia of Rh hemolytic disease.
    Ohls RK; Wirkus PE; Christensen RD
    Pediatrics; 1992 Nov; 90(5):678-80. PubMed ID: 1408538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Erythropoietin: its biological properties and clinical use].
    Ermolenko VM; Nikolaev AIu
    Ter Arkh; 1990; 62(11):141-5. PubMed ID: 2094979
    [No Abstract]   [Full Text] [Related]  

  • 12. Management of the anemia of chronic renal failure.
    Erslev AJ
    Clin Nephrol; 1974; 2(5):174-8. PubMed ID: 4426139
    [No Abstract]   [Full Text] [Related]  

  • 13. [Mechanisms of the onset of anemia in chronic renal insufficiency].
    Stefanović S; Savin S; Pendić S; Janćić M; Ristić M
    Srp Arh Celok Lek; 1972 Jan; 100(1):9-19. PubMed ID: 5028878
    [No Abstract]   [Full Text] [Related]  

  • 14. Recombinant human erythropoietin. Experimental and clinical applications.
    Nielsen OJ
    Dan Med Bull; 1991 Oct; 38(5):355-70. PubMed ID: 1802621
    [No Abstract]   [Full Text] [Related]  

  • 15. Benefits and costs of recombinant human erythropoietin for end-stage renal failure: a review. Benefits and costs of erythropoietin.
    McNamee P; van Doorslaer E; Segaar R
    Int J Technol Assess Health Care; 1993; 9(4):490-504. PubMed ID: 8288425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Use of human recombinant erythropoietin (rHuEPO) for treatment of anemia in patients with chronic kidney failure who don't require additional dialysis therapy].
    Wiecek A
    Przegl Lek; 1995; 52(3):93-4. PubMed ID: 7644683
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of recombinant human erythropoietin on the anemia of chronic renal failure.
    Urabe A; Takaku F; Mizoguchi H; Kubo K; Ota K; Shimizu N; Tanaka K; Mimura N; Nihei H; Koshikawa S
    Int J Cell Cloning; 1988 May; 6(3):179-91. PubMed ID: 3397592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of erythropoietin treatment on O2 affinity and performance in patients with renal anemia.
    Böcker A; Reimers E; Nonnast-Daniel B; Kühn K; Koch KM; Scigalla P; Braumann KM; Brunkhorst R; Böning D
    Contrib Nephrol; 1988; 66():165-75. PubMed ID: 3391031
    [No Abstract]   [Full Text] [Related]  

  • 19. Human recombinant erythropoietin: progress in clinical development.
    Kubiak W; Karwacki M; Mazur I
    Ann Univ Mariae Curie Sklodowska Med; 1994; 48 Suppl 3():39-50. PubMed ID: 8192531
    [No Abstract]   [Full Text] [Related]  

  • 20. [Biological similarity of erythropoietin: controlled maturation].
    Combe C
    Nephrol Ther; 2009 Feb; 5 Spec No1():1-2. PubMed ID: 19233074
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.